Event Brief
Sun Pharma to buy Organon in $11.75B deal
Filed: Apr 27, 2026 at 6:00 AM ET
Summary: Sun Pharmaceutical Industries will acquire U.S.-based Organon & Co in an all-cash deal valued at $11.75 billion.
WHO: Sun Pharmaceutical Industries
WHAT: will acquire Organon & Co in an all-cash deal
WHEN: Apr 27, 2026 at 2:49 AM ET
WHERE: India
WHY: To fuel its global ambitions.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →